Perceptive Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
Perceptive Advisors's CRVS Position: Q3 2026 in Review
Perceptive Advisors reduced its Corvus Pharmaceuticals (CRVS) stake by 5.9% in Q3 2026, selling an estimated $2.19M and leaving 2,510,441 shares worth $28.9M. The position accounts for 0.5% of the portfolio, ranked #38.
Perceptive Advisors first reported a position in CRVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $39.9M in Q2 2026. 177 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.
- Perceptive Advisors held 2,510,441 shares of Corvus Pharmaceuticals worth $28.9M as of Q3 2026.
- Perceptive Advisors sold 157,000 Corvus Pharmaceuticals shares in Q3 2026, an estimated $2.19M.
- Corvus Pharmaceuticals made up 0.5% of Perceptive Advisors's portfolio in Q3 2026, its #38 holding.
- Perceptive Advisors first reported a position in Corvus Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Perceptive Advisors's Corvus Pharmaceuticals position peaked at $39.9M in Q2 2026.
- 177 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.
Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.